Brand Name(s): Periactin
CAS nš: 129-03-3
(sip row HEP ta deen)
About Cyproheptadine
This new site is dedicated exclusively to cyproheptadine.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about cyproheptadine on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total cyproheptadine experience!
Why is this medication prescribed?
Cyproheptadine is an antihistamine. Cyproheptadine blocks the effects of the naturally occurring chemical histamine in your body.
Cyproheptadine is used to treat sneezing, runny nose, itchy and watery eyes, hives, rashes, itching, and other symptoms of allergies and the common cold.
Latest News
Stress level increases allergy!
According to a new study in Karolinska Institute in Stockholm, an important link has been found...
[more]Annoying Allergies: Ragweed Season
You may be noticing a lot of sniffles and sneezes in the office today or maybe you have a problem...
[more]Children's Allergies Increasing Worldwide
The number of children with allergies and asthma is increasing worldwide, especially among the...
[more]Evidence to support the use of Periactin (cyproheptadine hydrochloride) to stimulate appetite
We found a number of sources that discuss the use of cyproheptadine in stimulating the appetite....
[more]Antipsychotic drugs stop fatal viral infection in brain cells
Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system...
[more]